Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Asieris Starts EU Arm in Global Trial of Photodynamic Drug-Device Product

publication date: Jun 22, 2021

Shanghai Asieris Pharma dosed the first European patient in a global Phase III trial of its photodynamic drug-device combination product for cervical lesions. Cevira® is being developed as a novel non-surgical treatment for cervical high-grade squamous intraepithelial lesions. The drug-containing device contains a photosensitizer that activates the active ingredients via a specific wavelength of light. Asieris, which develops novel treatments for genitourinary tumors, in-licensed global rights to Cevira® from Photocure of Oslo in a $73 million agreement. More details....

Stock Symbol: (OSE: PHO)

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here